| Dr Michael Edward Black, MD | |
|
3600 Gaston Ave, Wadley Tower, Suite 261, Dallas, TX 75246-1800 | |
| (214) 823-6492 | |
| (214) 818-9180 |
| Full Name | Dr Michael Edward Black |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 30 Years |
| Location | 3600 Gaston Ave, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639108186 | NPI | - | NPPES |
| 83P753 | Other | TX | BLUE CROSS BLUE SHIELD |
| P00128419 | Other | TX | RAILROAD MEDICARE |
| 042638901 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | K1979 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Plano | Plano, TX | Hospital |
| Baylor Scott & White The Heart Hospital - Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathologists Bio-medical Laboratories Pllc | 7911961677 | 46 |
News Archive
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
Researchers recommend performing echocardiography at rest and during exercise to screen for pulmonary arterial hypertension in patients with systemic sclerosis.
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug - originally developed to tackle the scarring of organ tissue - could help to significantly improve the success rate of cancer immunotherapy treatment.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.
› Verified 9 days ago
| Entity Name | Pathologists Bio-medical Laboratories Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265477707 PECOS PAC ID: 7911961677 Enrollment ID: O20041112001162 |
News Archive
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
Researchers recommend performing echocardiography at rest and during exercise to screen for pulmonary arterial hypertension in patients with systemic sclerosis.
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug - originally developed to tackle the scarring of organ tissue - could help to significantly improve the success rate of cancer immunotherapy treatment.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Edward Black, MD 3600 Gaston Ave, Barnett Tower, Suite 707, Dallas, TX 75246-1800 Ph: (214) 823-6492 | Dr Michael Edward Black, MD 3600 Gaston Ave, Wadley Tower, Suite 261, Dallas, TX 75246-1800 Ph: (214) 823-6492 |
News Archive
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible.
Researchers recommend performing echocardiography at rest and during exercise to screen for pulmonary arterial hypertension in patients with systemic sclerosis.
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug - originally developed to tackle the scarring of organ tissue - could help to significantly improve the success rate of cancer immunotherapy treatment.
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer." DelMar's data was presented on Sunday, April 6, 2014 during the Novel Cytotoxic Strategies Session at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.
Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.
› Verified 9 days ago
Dr. Jaime Albert Campbell, M.D., M.S. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, Baylor University Medical Center, Dept Of Pathology, Dallas, TX 75246 Phone: 214-820-3772 | |
Brianne Flynn, Pathology Medicare: Not Enrolled in Medicare Practice Location: 2355 N Stemmons Fwy, Dallas, TX 75207 Phone: 214-920-5900 | |
Dr. Timothy Joseph Kirtek, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd Stop 7200, Dallas, TX 75390 Phone: 214-648-3433 | |
Keith Allen Wharton Jr., MD PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080 | |
Dinesh Rakheja, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080 | |
Dr. Emmy L. Kiss, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-590-6494 | |
Thomas Hugh Mcconnell, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3401 Lee Pkwy Apt 304, Dallas, TX 75219 Phone: 214-363-2221 Fax: 214-363-2228 |